Role of EBUS-TBNA in Diagnosing TB in Mediastinal/Hilar Lymph Nodes
NCT ID: NCT01350674
Last Updated: 2018-07-31
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
SUSPENDED
NA
50 participants
INTERVENTIONAL
2010-12-31
2018-03-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
The investigators analyse the specificity and sensibility of this technique to diagnose tuberculosis in mediastinal and/or hilar lymph nodes.
Patients with mediastinal and/or hilar lymph nodes on X-ray or CT thorax where a tuberculosis is the most probable cause and who have no parenchymal lesions suspected for tuberculosis and without other lymph nodes that are more easily accessible or palpable will be included in this study.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Conventional Versus Ultrasound-guided Transbronchial Needle Aspiration for the Diagnosis of Hilar/Mediastinal Lymphadenopathies
NCT01658280
Value of Rapid on Site Evaluation During EBUS-guided TBNA in the Diagnosis of Mediastinal Lesions
NCT02690610
Accuracy and Safety of Endobronchial Ultrasound (EBUS) in Suspected Non-malignant Mediastinal Lymphadenopathy
NCT02398864
EBUS-guided TBNA for Molecular Diagnostic of Mediastinal Lymph Nodes (LN)
NCT00982605
EBUS-TBNA Versus EBUS-TBNB
NCT01467635
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
DIAGNOSTIC
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
EBUS
patients undergoing EBUS
EBUS-TBNA
endobronchial ultrasound transbronchial needle aspiration
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
EBUS-TBNA
endobronchial ultrasound transbronchial needle aspiration
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* patients aged 18 years or older
* patients need to sign the consent form after reading the information form
Exclusion Criteria
* other affected ganglionary sites more easily accessible (cervical, supraclavicular, axillary ... region)
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Centre Hospitalier Universitaire Saint Pierre
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Inge M Muylle, MD
Role: PRINCIPAL_INVESTIGATOR
CHU St. Pierre Brussels
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
CHU St. Pierre; pulmonology department
Brussels, , Belgium
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
AK/10-10-3949/67
Identifier Type: OTHER
Identifier Source: secondary_id
B07620109427
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.